Abbott Labs’ $23 billion deal to acquire Madison’s Exact Sciences set to close Monday

Abbott finalizes purchase of Madison-based Exact Sciences

It had been announced last November that Abbott would acquire the company.

Abbott Labs’ $23 billion deal to acquire Madison’s Exact Sciences set to close Monday

The deal is believed to be one of the largest for Abbott in a decade and the largest business investment in the Madison’s history.

Abbott Closes $21B Exact Sciences Deal; Madison Operations Stay

Abbott completed its $21B takeover of Exact Sciences, paying $105 per share and keeping the company's Madison operations and leadership in place.

Abbott completes acquisition of Exact Sciences

ABBOTT PARK, Ill. — Abbott has finalized its acquisition of Exact Sciences, strengthening its position in the rapidly growing cancer screening and diagnostics market and significantly expanding its reach in early detection and precision oncology.The deal makes Exact Sciences a wholly owned subsidiary of Abbott, with March 20 being the last day for trading Exact Sciences shares on the Nasdaq. Financial terms were not disclosed.Abbott chairman and…

Abbott Finalizing $21 Billion Acquisition of Exact Sciences

Abbott is set to close its $21 billion acquisition of cancer-screening specialist Exact Sciences on Monday, having successfully secured all necessary regulatory approvals. This landmark deal, the largest in the medtech sector over the past year, integrates Exact Sciences’ prominent diagnostic tools—including the noninvasive Cologuard test and emerging blood-based cancer screenings—into Abbott’s global portfolio. Abbott CEO Robert Ford highlighte…

Abbott to close acquisition of Exact Sciences

This transaction is expected to add approximately $3 billion of incremental sales in 2026